STE STERIS plc
STE STERIS plc
Healthcare · Medical Devices
Desk view
Market read
POC $212.17 · VWAP $230.13 · +0.9% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
STE Price Structure
Loading timeframes…
Peers
Every watchlist STE belongs to, members best 30-day change first — STE highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@trace-glp1-manufacturing
Reported the quarter ending 2026-06-30: revenue $1.49B, diluted EPS $2.04, net income $200M (SEC filing). Across the print the stock moved -0.5% (close before → first close after).
full note →Against street estimates
How STE's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
News (last pull)
Headlines about STE from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 22 days ago · Oct 1
STE research tape
1 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.